Phytosterol intake with natural foods, a measure of healthy dietary choices, increases plasma levels, but increased plasma
phytosterols are believed to be a
coronary heart disease (CHD) risk factor. To address this paradox, we evaluated baseline risk factors,
phytosterol intake, and plasma noncholesterol
sterol levels in participants of a case control study nested within the European Prospective Investigation into
Cancer and Nutrition (EPIC) Spanish cohort who developed CHD (n = 299) and matched controls (n = 584) who remained free of CHD after
a 10 year follow-up.
Sitosterol-to-
cholesterol ratios increased across tertiles of
phytosterol intake (P = 0.026).
HDL-cholesterol level increased, and adiposity measures,
cholesterol/HDL ratios, and levels of
glucose,
triglycerides, and
lathosterol, a
cholesterol synthesis marker, decreased across plasma
sitosterol tertiles (P < 0.02; all). Compared with controls, cases had nonsignificantly lower median levels of
phytosterol intake and plasma
sitosterol. The multivariable-adjusted odds ratio for CHD across the lowest to highest plasma
sitosterol tertile was 0.59 (95% confidence interval, 0.36-0.97). Associations were weaker for plasma
campesterol. The
apolipoprotein E genotype was unrelated to CHD risk or plasma
phytosterols. The data suggest that plasma
sitosterol levels are associated with a lower CHD risk while being markers of a lower cardiometabolic risk in the EPIC-Spain cohort, a population with a high
phytosterol intake.